The discovery and development of an HIV/AIDS vaccine for the prevention of HIV infection is one of the top priorities at NIAID. As such, the VRP, which is divided into the Preclinical Research and Development Branch and Vaccine Clinical Research Branch, supports basic, preclinical, and clinical research of candidate vaccines through the following activities:
For more information on NIAID HIV vaccine research efforts, visit the HIV/AIDS Vaccine Research Area.
back to top
Last Updated October 29, 2007